Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis

Frontiers in Cellular and Infection Microbiology - Switzerland
doi 10.3389/fcimb.2019.00353
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Epidemiology of Visceral Leishmaniasis in Algeria: An Update

PLoS ONE
Multidisciplinary
2014English

Efficacies of KY62 Against Leishmania Amazonensis andLeishmania Donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Visceral Leishmaniasis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1993English

Epidemiology of Visceral Leishmaniasis in Georgia

Online Journal of Public Health Informatics
2017English

Treatment of Experimental Visceral Leishmaniasis With Amphotericin B in Stable Albumin Microspheres

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Prolonged Blood Circulation Time of Antimony in Dogs With Visceral Leishmaniasis From Liposomes With 175-Nm Diameter

Journal of Nanomedicine & Biotherapeutic Discovery
2011English

Tissue and Host Species-Specific Transcriptional Changes in Models of Experimental Visceral Leishmaniasis

Wellcome Open Research
BiochemistryMedicineGeneticsMolecular Biology
2019English

Activity of Oral Atovaquone Alone and in Combination With Antimony in Experimental Visceral Leishmaniasis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

Modulation of T-Cell Costimulation as Immunotherapy or Immunochemotherapy in Experimental Visceral Leishmaniasis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy